A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in Japan
Study Identifier
M16-119
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18+ years
Protocol Summary
This study is designed to investigate the efficacy, safety and pharmacokinetics of adalimumab in subjects in Japan with active ulcer(s) due to Pyoderma Gangrenosum (PG).
Study Locations
Location
Status
Location
Nagoya City University Hospital /ID# 164510
Nagoya, Aichi-ken, Japan, 467-8602
Status
Not applicable
Location
Juntendo University Urayasu Hospital /ID# 164422
Urayasu Shi, Chiba, Japan, 279-0021
Status
Not applicable
Location
Fukuoka University Hospital /ID# 164416
Fukuoka, Fukuoka, Japan, 814-0180
Status
Not applicable
Location
Fukushima Medical University Hospital /ID# 164358
Fukushima, Fukushima, Japan, 960-1295
Status
Not applicable
Location
Gunma University Hospital /ID# 164464
Maebashi, Gunma, Japan, 371-8511
Status
Not applicable
Location
Asahikawa Medical University Hospital /ID# 164589
Asahikawa-shi, Hokkaido, Japan, 078-8510
Status
Not applicable
Showing {first} - {last} of {total} Results